Janssen, PAJ; Jageneau, AHM; Demoen, PJA; van De. Westeringh, C; Raeymaekers, AHM; Wouters, MSJ; Sanczuk, S; Hermans, BKF; Loomans, JLM. Compounds related to pethidine--I. Mannich bases derived from norpethidine and acetophenones. J. Med. Chem., 1 Feb 1959, 1 (1), 105–120. 695 kB. https://doi.org/10.1021/jm50002a008 #45
Brandt, SD; Kavanagh, PV. Addressing the challenges in forensic drug chemistry. Drug Test. Anal., 1 Mar 2017, 9 (3), 342-346. 120 kB. https://doi.org/10.1002/dta.2169
Balayssac, S; Retailleau, E; Bertrand, G; Escot, M; Martino, R; Malet-Martino, M; Gilard, V. Characterization of heroin samples by 1H NMR and 2D DOSY 1H NMR. Forensic Sci. Int., 1 Jan 2014, 234, 29-38. 1.4 MB. https://doi.org/10.1016/j.forsciint.2013.10.025
Johnson, MW; Griffiths, RR; Hendricks, PS; Henningfield, JE. The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act. Neuropharmacology, 1 Jun 2018, n/a. 2.5 MB. https://doi.org/10.1016/j.neuropharm.2018.05.012 #Codeine
Chambers, SA; DeSousa, JM; Huseman, ED; Townsend, SD. The DARK side of total synthesis: Strategies and tactics in psychoactive drug production. ACS Chem. Neurosci., 17 Oct 2018, 9 (10), 2307–2330. 8.1 MB. https://doi.org/10.1021/acschemneuro.7b00528 #2
Ellis, CR; Kruhlak, NL; Kim, MT; Hawkins, EG; Stavitskaya, L. Predicting opioid receptor binding affinity of pharmacologically unclassified designer substances using molecular docking. PLOS ONE, 24 May 2018, 13 (5), e0197734. 5.5 MB. https://doi.org/10.1371/journal.pone.0197734 #Codeine